FDA Drug Updates
Xaciato (clindamycin phosphate vaginal gel, 2%) a vaginal gel, for treatment of bacterial vaginosis, is approved by Food and Drug Administration (FDA), in females aged 12 years and older. Bacterial vaginosis is the most common cause of vaginitis globally and is more prevalent in Black and Hispanic women than white women. It is caused due to overgro
FDA Approves a Vaginal Gel for Bacterial Vaginosis

FDA Approves a Vaginal Gel for Bacterial Vaginosis

1640 Reached1 Comments

Similar Content

Pregnant Woman with HIV-1 Infection
Pregnant Woman with HIV-1 Infection
747 Reached1 Likes
<p>Use of Clindamycin for Managing Bacterial Vaginosis</p>

Use of Clindamycin for Managing Bacterial Vaginosis

10822 Reached28 Comments8 Likes
Male with Right Testicular Fracture post Accident
Male with Right Testicular Fracture post Accident
272 Reached2 Comments
Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1004 Reached2 Comments
Impact of Epidural Anesthesia during Labor in Pregnant Females with Cardiovascular Risks
Impact of Epidural Anesthesia during Labor in Pregnant Females with Cardiovascular Risks
497 Reached1 Comments3 Likes